Tag: Europe
-
Diagnostics Developer Secures $100M Series C Financing
Biocartis, a diagnostic systems company in Lausanne, Switzerland says it completed raising €71 million (US$100 million) in series C equity funds, led by the company’s senior management and backed by current and new investors, as well as industrial collaborators. Series C financing is the third round of equity funding after start-up. Biocartis develops compact molecular…
-
Dried Blood Test Developed, Spin-Off Company Formed
Researchers at King’s College London have developed a process to screen patients for genetic and acquired clinical conditions from a single dried blood spot. The college also started today a spin-off diagnostics company providing services using this method. The test, developed by a team from King’s College and clinician collaborators from King’s Health Partners Academic…
-
Trial of Insulin-Coated Gold Nanoparticles Approved
Midatech Ltd. in Oxford, U.K. says it has received approval from regulatory authorities in Switzerland for a clinical trial of the company’s insulin-coated gold nanoparticles. The company says it is the first test in humans of therapies based on solid nanoparticles. Midatech says the trial will test the safety of insulin-coated gold nanoparticles when applied…
-
Protein Discovered That Enables Heart Tissue Repair
Researchers at the Max Planck Institute for Heart and Lung Research in Bad Nauheim, Germany have found a protein that stimulates regression of individual heart muscle cells into their precursor cells, a step required for self-generated healing of damaged heart tissue. The Max Planck Institute, with colleagues from the Schüchtermann Klinik in Bad Rothenfelde, published…
-
Algorithms Track Individual Athletes During Sports Events
Computer algorithms developed by Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland make it possible to visually track individual players in action on sports teams. The technology developers, from EPFL’s Computer Vision Laboratory, present their findings today at the International Conference on Computer Vision in Barcelona. The system can track multiple players in fast-moving sports…
-
Depression Drug Fails in First Phase 3 Trial
A drug candidate designed to treat major depressive disorder has not met its success targets in the first round of phase 3 clinical trials. The drug, TC-5214 (S-mecamylamine), is made by global pharmaceutical company AstraZeneca and Targacept Inc., biotechnology company in Winston-Salem, North Carolina. The clinical trial tested TC-5214 as a therapy for major depressive…
-
Researchers Give Robotics a Human Face
Research engineers at Technical University of Munich (Technische Universitaet Muenchen, TUM) in Germany and the National Institute of Advanced Industrial Science and Technology in Japan have developed a way to give robots a human-like plastic head. Called Mask-bot, the technology may have a more immediate application as a tool to create avatars for participants in…
-
Driver Health Monitors Developed for Passenger Cars
A research team at the Technical University of Munich (Technische Universitaet Muenchen, TUM) in Germany and the BMW Group devised a sensor system that can monitor the driver’s state of health while driving. The scientific team led by TUM’s professor Tim Lueth published their findings in a recent issue of the technical journal ATZ Online…
-
Laser Technique Developed for Microscale Tissue Engineering
A research team from Laser Zentrum Hannover (LZH) eV Institute in Hannover, Germany, and the Joint Department of Biomedical Engineering at University of North Carolina at Chapel Hill and North Carolina State University in Raleigh has devised a technique to produce finely detailed scaffolds on which human cells can grow to replace lost or damaged…
-
Math Model Detects Financial Asset Bubbles
Statisticians in the U.S. and France have devised a mathematical model that they say can detect asset bubbles, such as vastly over-valued stocks, in real time. Robert Jarrow of Cornell University and risk management company Kamakura Corp. in Honolulu, Younes Kchia at Ecole Polytechnique in Paris, and Philip Protter of Columbia University published their findings…